US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enlivex Therapeutics Ltd.

0.9000

-0.0400-4.26%

Post-market: 0.93450.0345+3.83%16:06 EDT

Volume:21.99K

Turnover:20.04K

Market Cap:21.32M

PE:-1.36

High:0.9240

Open:0.9240

Low:0.9000

Close:0.9400

Loading ...

Overview Company News Filings

Enlivex Therapeutics Announces Presentation of Promising Allocetra™ Clinical Trial Data in Knee Osteoarthritis at EULAR 2025

Enlivex Therapeutics Ltd. Reports No Revenue, Increased Loss for Q1 2025

Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference

Enlivex Therapeutics Ltd. to Present Macrophage Reprogramming Therapy at Israeli BioMed 2025 Conference

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress

Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis

Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Analysts Offer Insights on Healthcare Companies: Harvard Bioscience (HBIO) and Enlivex (ENLV)

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital

Enlivex announces interim 6-month efficacy data from Phase I of Allocetra trial

Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis

Enlivex Therapeutics (NASDAQ:ENLV) Hails Positive Trial Results for Allocetra Treatment of Knee Osteoarthritis

Enlivex Issues Urgent Statement on Fraudulent News Dissemination

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ENLV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENLV\",,,,,undefined,":{"symbol":"ENLV","market":"US","secType":"STK","nameCN":"Enlivex Therapeutics Ltd.","latestPrice":0.9,"timestamp":1749844800000,"preClose":0.94,"halted":0,"volume":21988,"hourTrading":{"tag":"盘后","latestPrice":0.9345,"preClose":0.9,"latestTime":"16:06 EDT","volume":2001,"amount":1869.89,"timestamp":1749845163154},"delay":0,"floatShares":20804357,"shares":23685279,"eps":-0.66406,"marketStatus":"Market Closed","change":-0.04,"latestTime":"06-13 16:00:00 EDT","open":0.924,"high":0.924,"low":0.9,"amount":20041.03061,"amplitude":0.025532,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.66406,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1406779200000,"exchange":"NASDAQ","adjPreClose":0.94,"postHourTrading":{"tag":"盘后","latestPrice":0.9345,"preClose":0.9,"latestTime":"16:06 EDT","volume":2001,"amount":1869.89,"timestamp":1749845163154},"volumeRatio":0.6077525239771189,"impliedVol":0.4482,"impliedVolPercentile":0.068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENLV\",,,,,undefined,":{"symbol":"ENLV","floatShares":20804357,"roa":"-34.24%","roe":"-60.35%","lyrEps":-0.73189,"volumeRatio":0.6077525239771189,"shares":23685279,"dividePrice":0,"high":0.924,"amplitude":0.025532,"preClose":0.94,"low":0.9,"week52Low":0.8101,"pbRate":"1.03","week52High":1.76,"institutionHeld":0,"latestPrice":0.9,"eps":-0.66406,"divideRate":0,"volume":21988,"delay":0,"ttmEps":-0.66406,"open":0.924,"prevYearClose":1.17,"prevWeekClose":0.9674,"prevMonthClose":0.936,"prevQuarterClose":0.9702,"fiveDayClose":0.9674,"twentyDayClose":1.03,"sixtyDayClose":1.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENLV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542331490","title":"Enlivex Therapeutics Announces Presentation of Promising Allocetra™ Clinical Trial Data in Knee Osteoarthritis at EULAR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542331490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542331490?lang=en_us&edition=fundamental","pubTime":"2025-06-10 20:32","pubTimestamp":1749558772,"startTime":"0","endTime":"0","summary":"Enlivex Therapeutics Ltd.  has announced that it will present clinical data from its ongoing study of Allocetra, a macrophage reprogramming cell therapy, at the European Alliance of Associations for Rheumatology  European Congress of Rheumatology. The conference is scheduled to take place from June 11-14, 2025, in Barcelona, Spain. The presentation will feature data from a Phase I/II trial evaluating Allocetra in patients with knee osteoarthritis. The therapy has shown promising results in terms of safety and efficacy, including pain reduction and improved joint function. The company has completed patient enrollment for the Phase II stage of the trial and anticipates releasing topline data by August 2025. Enlivex representatives, including CEO Dr. Oren Hershkovitz and CMO Dr. Einat Galamidi, will attend the conference to engage with stakeholders and the scientific community.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL4N1hkK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","ENLV","BK4585","BK4139","IE00BGHQF748.EUR","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2539085392","title":"Enlivex Therapeutics Ltd. Reports No Revenue, Increased Loss for Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2539085392","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539085392?lang=en_us&edition=fundamental","pubTime":"2025-05-31 04:31","pubTimestamp":1748637089,"startTime":"0","endTime":"0","summary":"Enlivex Therapeutics Ltd. has released its unaudited financial results for the first quarter ending March 31, 2025. The company reported no revenue for the period, consistent with the same quarter in 2024. The net loss for the quarter was $3.452 million, an improvement from a net loss of $4.140 million in the same period last year. Research and development expenses decreased to $2.550 million from $2.857 million, and general and administrative expenses fell to $954,000 from $1.093 million in the previous year. Enlivex's management and board of directors remain optimistic about the company's financial resources, stating they are sufficient to continue product development for at least the next twelve months. However, the company may seek additional capital within this period. The long-term operational viability of Enlivex is dependent on further financial support and the successful development and revenue generation from its product candidates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL7RBZHl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Enlivex Therapeutics Ltd. Reports No Revenue, Increased Loss for Q1 2025","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENLV"],"gpt_icon":0},{"id":"2536612292","title":"Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2536612292","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536612292?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:15","pubTimestamp":1747743313,"startTime":"0","endTime":"0","summary":"Enlivex Therapeutics (ENLV) announced that the Company has been selected to present at the upcoming Israeli BioMed 2025 Conference, taking place Ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enlivex-therapeutics-selected-to-present-at-israeli-biomed-2025-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enlivex-therapeutics-selected-to-present-at-israeli-biomed-2025-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539","ENLV"],"gpt_icon":0},{"id":"2536128106","title":"Enlivex Therapeutics Ltd. to Present Macrophage Reprogramming Therapy at Israeli BioMed 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2536128106","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536128106?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:00","pubTimestamp":1747742458,"startTime":"0","endTime":"0","summary":"Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, will present at the Israeli BioMed 2025 Conference from May 21-23, 2025, in Tel Aviv, Israel. The presentation, titled \"Enlivex-Harnessing the Natural Healing Power of Macrophages to Treat Inflammatory Diseases,\" will be delivered by the Company's CEO on May 21st. It will highlight Allocetra and the therapeutic potential of macrophage reprogramming in treating inflammatory diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enlivex Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire  on May 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL77Q7jv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","LU2095319765.USD","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","ENLV","LU2210150020.SGD","BK4139"],"gpt_icon":0},{"id":"2529631683","title":"Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631683","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631683?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:30","pubTimestamp":1745411400,"startTime":"0","endTime":"0","summary":"Presentations to underscore AllocetraTM’s novel mechanism targeting immune imbalance in joint disease. Ness-Ziona, Israel, April 23, 2025  -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the Osteoarthritis Research Society International  2025 World Congress on Osteoarthritis, taking place April 24-27, 2025, in Incheon , South Korea.“These presentations at OARSI 2025 will highlight the growing body of evidence supporting Allocetra’sTM potential as a novel therapeutic approach for osteoarthritis,” said Oren Hershkovitz, PhD, Chief Executive Officer of Enlivex. “We believe that restoring macrophage homeostasis may address the underlying drivers of chronic joint inflammation and cartilage degradation, potentially offering a promising new treatment pathway for millions of patients worldwide.”The presentations will feature data from both preclinical and clinical studies evaluating All","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-therapeutics-showcase-allocetra-potential-123000648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","ENLV","BK4139","BK4007"],"gpt_icon":0},{"id":"2529576806","title":"Enlivex Announces Completion of Enrollment In The Phase II stage Of  Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2529576806","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529576806?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238600,"startTime":"0","endTime":"0","summary":"Nes-Ziona, Israel, April 21, 2025  -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Company completed enrollment of all patients in the Phase II stage of its randomized, controlled, blinded Phase I/II trial of Allocetra in patients with moderate to severe knee osteoarthritis. Overall, 133 patients were randomized and treated in the Phase II stage.Oren Hershkovitz, Ph.D, CEO of Enlivex, commented, “We are pleased to have completed the recruitment of patients in the Phase II stage of this trial, which follows the recently announced promising initial efficacy data from the Phase I stage. We therefore reiterate our timeline objective to obtain 3-month topline data by August 2025. We believe Allocetra has the potential to transform the way osteoarthritis patients are being treated today, and we are eager to receive the topline data of the trial.”Osteoarthritis is by far the most common form of arthritis, affecting more ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-announces-completion-enrollment-phase-123000491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ENLV","BK4139"],"gpt_icon":0},{"id":"2524926370","title":"Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2524926370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524926370?lang=en_us&edition=fundamental","pubTime":"2025-04-03 22:03","pubTimestamp":1743688980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENLV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 10:03 ET (14:03 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ENLV"],"gpt_icon":0},{"id":"2524251158","title":"Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2524251158","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524251158?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:00","pubTimestamp":1743681600,"startTime":"0","endTime":"0","summary":"Temporomandibular joint  osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to 12% of the population globally. TMJ causes pain and stiffness in the jaw, making it difficult to chew. TMJ osteoarthritis currently has no long-term effective treatments. Ness-Ziona, Israel, April 03, 2025  -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that the first patient has been dosed in an investigator-initiated Phase I trial to evaluate the safety, tolerability and initial efficacy of Allocetra for injection into the temporomandibular joint  in patients suffering from TMJ osteoarthritis.Dr. Einat Galamidi, CMO of Enlivex, commented, “This study will provide a preliminary evaluation of the safety and potential effect of AllocetraTM for the treatment of TMJ osteoarthritis, which affects a joint that is critical for daily function. We are pleased to report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-announces-dosing-first-patient-120000506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ENLV","BK4139"],"gpt_icon":0},{"id":"2522606203","title":"Analysts Offer Insights on Healthcare Companies: Harvard Bioscience (HBIO) and Enlivex (ENLV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522606203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522606203?lang=en_us&edition=fundamental","pubTime":"2025-03-25 14:30","pubTimestamp":1742884215,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Harvard Bioscience (HBIO – Research Report) and Enli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harvard-bioscience-hbio-and-enlivex-enlv?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harvard-bioscience-hbio-and-enlivex-enlv?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENLV","BK4137","BK4121","HCSG","BK4139","HBIO"],"gpt_icon":0},{"id":"2520522829","title":"Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2520522829","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520522829?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:00","pubTimestamp":1742212800,"startTime":"0","endTime":"0","summary":"Nes-Ziona, Israel, March 17, 2025  -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that the China National Intellectual Property Administration  issued a notice of allowance for patent application number 2020800620493. Once issued, the resulting patent will provide Enlivex with added intellectual property protection in China through at least 2040 with claims covering methods of using Allocetra to treat subjects with osteoarthritis. The Company expects that this new patent will be issued in China during the first half of 2025.Enlivex recently reported positive interim six  months efficacy data from the first stage of its ongoing randomized, multi-country Phase I/II Allocetra trial in patients with moderate to severe knee osteoarthritis.Statistically significant, 47.0% average reduction of reported pain , compared to average pain level at baseline. 46% improvement in joint function and 40% improvement in joint stiffness. Eff","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-receives-notice-allowance-chinese-120000844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ENLV","BK4139"],"gpt_icon":0},{"id":"2516584486","title":"Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2516584486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516584486?lang=en_us&edition=fundamental","pubTime":"2025-03-03 23:54","pubTimestamp":1741017240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENLV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 10:54 ET (15:54 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ENLV"],"gpt_icon":0},{"id":"2516635024","title":"Enlivex announces interim 6-month efficacy data from Phase I of Allocetra trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635024","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635024?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:25","pubTimestamp":1741008339,"startTime":"0","endTime":"0","summary":"Enlivex Therapeutics (ENLV) announced positive interim six-month efficacy data from the Phase I stage of its randomized, multi-country Phase I/II A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/enlivex-announces-interim-6-month-efficacy-data-from-phase-i-of-allocetra-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/enlivex-announces-interim-6-month-efficacy-data-from-phase-i-of-allocetra-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENLV"],"gpt_icon":0},{"id":"2516463995","title":"Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2516463995","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516463995?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:22","pubTimestamp":1741008120,"startTime":"0","endTime":"0","summary":"Nes-Ziona, Israel, March 03, 2025  -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim six-month efficacy data from the Phase I stage of its randomized, multi-country Phase I/II Allocetra trial in patients with moderate to severe knee osteoarthritis.46% improvement in joint function and 40% improvement in joint stiffness. The Company previously announced positive 3-month interim safety and efficacy results for the first 12 patients treated in the Phase I stage. The previously announced data demonstrated a marked statistically significant improvements in all key efficacy endpoints, including 50%1average pain reduction and 42% and 37% improvement in functionality and stiffness, respectively, compared to the baseline2. All 12 patients in the Phase I stage completed the assessment at 6 months following the last injection3, and the data from such assessments showed a statistically significant 47.0% average reductio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-announces-positive-interim-data-132200300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ENLV"],"gpt_icon":0},{"id":"2512668951","title":"Enlivex Therapeutics (NASDAQ:ENLV) Hails Positive Trial Results for Allocetra Treatment of Knee Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512668951","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512668951?lang=en_us&edition=fundamental","pubTime":"2025-02-18 22:30","pubTimestamp":1739889004,"startTime":"0","endTime":"0","summary":"Israeli macrophage reprogramming immunotherapy company Enlivex Therapeutics ($ENLV) announced “highly positive” clinical trial results for its nove...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/enlivex-therapeutics-nasdaqenlv-hails-positive-trial-results-for-allocetra-treatment-of-knee-osteoarthritis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/enlivex-therapeutics-nasdaqenlv-hails-positive-trial-results-for-allocetra-treatment-of-knee-osteoarthritis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":[".IXIC","MNQmain","NQmain","LU2210150020.SGD","PSQ","BK4588","ENLV","NVIW.SI","TQQQ","TSYW.SI","IE00B64PRP62.GBP","USAW.SI","NDAQ","QID","IE00B3QW5Z07.USD","USJW.SI","LU2095319765.USD","QLD","IE00BGHQF748.EUR","BK4139","BK4585","IE00BKPKM429.USD","LU2210149790.SGD","SQQQ","BK4112"],"gpt_icon":0},{"id":"2512615325","title":"Enlivex Issues Urgent Statement on Fraudulent News Dissemination","url":"https://stock-news.laohu8.com/highlight/detail?id=2512615325","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512615325?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:20","pubTimestamp":1739877600,"startTime":"0","endTime":"0","summary":"Ness-Ziona, Israel, Feb. 18, 2025  -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, alerts investors and the public that a completely false and misleading report regarding the Company was intentionally published this morning by the website Tipranks.com claiming that the Company has suspended its stock trading due to an internal investigation. These reports are completely unfounded and constitute fake news. The Company continues to operate normally, and its shares continue to trade regularly on the Tel Aviv Stock Exchange and NASDAQ Stock Exchange without any interruption.The Company unequivocally denies the claims made in this false report and urges investors to rely only on official communications from the Company, including press releases, filings with the U.S. Securities and Exchange Commission, and statements from verified Company channels.Investors and stakeholders with concerns or questions are encouraged to contact Shachar Shlosberg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enlivex-issues-urgent-statement-fraudulent-112000943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ENLV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENLV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-30","symbol":"ENLV","fiscalQuarterEnding":"2025/03","expectedEps":-0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1748577600000,"reportTimeType":"post","actualEps":-0.15},{"date":"2023-09-11","symbol":"ENLV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1694419200000,"name":null,"time":"Pre-Market","dateTimestamp":1694404800000,"actualEps":null},{"market":"US","date":"2023-06-26","symbol":"ENLV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1687752000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2023-04-04","symbol":"ENLV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1680580800000,"reportTimeType":"pre","actualEps":null},{"date":"2022-12-19","symbol":"ENLV","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1671440400000,"name":null,"time":"","dateTimestamp":1671426000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENLV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENLV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1724817600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENLV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENLV","date":"2025-06-13","current":-1.554109,"percent":0.718699,"low":-42.250582,"twenty":-11.33139,"median":-2.925136,"eighty":-1.391372,"high":-0.807503,"avg":-6.44498,"sd":7.062156,"marketCap":22264162},"quantilePoints":[{"date":"2020-06-19","current":-10.527112,"twenty":-33.735282,"median":-11.988581,"eighty":-9.552984,"marketCap":79090189},{"date":"2020-06-26","current":-11.027551,"twenty":-33.504338,"median":-11.768121,"eighty":-9.576846,"marketCap":82849994},{"date":"2020-07-02","current":-9.45474,"twenty":-33.462966,"median":-11.639761,"eighty":-9.533096,"marketCap":71033464},{"date":"2020-07-10","current":-9.229126,"twenty":-33.427523,"median":-11.600956,"eighty":-9.509858,"marketCap":69338420},{"date":"2020-07-17","current":-10.358125,"twenty":-33.350884,"median":-11.507353,"eighty":-9.50002,"marketCap":77820596},{"date":"2020-07-24","current":-9.874268,"twenty":-33.179332,"median":-11.474968,"eighty":-9.508359,"marketCap":74185378},{"date":"2020-07-31","current":-9.784665,"twenty":-32.588683,"median":-11.438542,"eighty":-9.509858,"marketCap":73512189},{"date":"2020-08-07","current":-9.408332,"twenty":-32.507148,"median":-11.42838,"eighty":-9.509858,"marketCap":70684797},{"date":"2020-08-14","current":-7.877187,"twenty":-32.203308,"median":-11.306688,"eighty":-9.50002,"marketCap":71627261},{"date":"2020-08-21","current":-7.270111,"twenty":-32.103906,"median":-11.237452,"eighty":-9.473006,"marketCap":66107115},{"date":"2020-08-28","current":-7.921607,"twenty":-31.963839,"median":-11.190585,"eighty":-9.45474,"marketCap":72031174},{"date":"2020-09-04","current":-7.358951,"twenty":-31.93161,"median":-11.135142,"eighty":-9.364312,"marketCap":66914941},{"date":"2020-09-11","current":-7.373758,"twenty":-31.809517,"median":-11.116916,"eighty":-9.32963,"marketCap":67049579},{"date":"2020-09-18","current":-7.81796,"twenty":-31.762012,"median":-11.079649,"eighty":-9.281178,"marketCap":71088710},{"date":"2020-09-25","current":-7.329338,"twenty":-31.447537,"median":-11.071367,"eighty":-9.139522,"marketCap":66645666},{"date":"2020-10-02","current":-15.324978,"twenty":-31.277823,"median":-11.064989,"eighty":-9.043665,"marketCap":139350029},{"date":"2020-10-09","current":-17.442343,"twenty":-30.847326,"median":-11.078127,"eighty":-9.07941,"marketCap":158603222},{"date":"2020-10-16","current":-19.530093,"twenty":-30.60981,"median":-11.102961,"eighty":-9.139522,"marketCap":177587139},{"date":"2020-10-23","current":-20.973581,"twenty":-30.605914,"median":-11.135142,"eighty":-9.214884,"marketCap":190712775},{"date":"2020-10-30","current":-18.001963,"twenty":-30.589877,"median":-11.190585,"eighty":-9.229126,"marketCap":158903323},{"date":"2020-11-06","current":-18.752044,"twenty":-30.554331,"median":-11.237452,"eighty":-9.276012,"marketCap":165524295},{"date":"2020-11-13","current":-15.132084,"twenty":-30.246813,"median":-11.306688,"eighty":-9.281178,"marketCap":133570909},{"date":"2020-11-20","current":-13.925431,"twenty":-30.090084,"median":-11.42838,"eighty":-9.293885,"marketCap":122919781},{"date":"2020-11-27","current":-14.05588,"twenty":-29.543927,"median":-11.438457,"eighty":-9.296979,"marketCap":124071254},{"date":"2020-12-04","current":-18.458534,"twenty":-29.293282,"median":-11.464493,"eighty":-9.300197,"marketCap":162933480},{"date":"2020-12-11","current":-16.550717,"twenty":-28.726626,"median":-11.479528,"eighty":-9.323866,"marketCap":146093182},{"date":"2020-12-18","current":-17.757371,"twenty":-28.589355,"median":-11.575956,"eighty":-9.343904,"marketCap":156744311},{"date":"2020-12-24","current":-17.023595,"twenty":-28.468598,"median":-11.624687,"eighty":-9.347491,"marketCap":150267273},{"date":"2020-12-31","current":-13.746064,"twenty":-28.173958,"median":-11.643303,"eighty":-9.35412,"marketCap":121336505},{"date":"2021-01-08","current":-15.931538,"twenty":-27.574936,"median":-11.920309,"eighty":-9.364578,"marketCap":140627683},{"date":"2021-01-15","current":-17.336289,"twenty":-27.118197,"median":-12.046285,"eighty":-9.382558,"marketCap":153027427},{"date":"2021-01-22","current":-19.914422,"twenty":-27.024496,"median":-12.223595,"eighty":-9.409419,"marketCap":175784604},{"date":"2021-01-29","current":-19.749157,"twenty":-26.84195,"median":-12.469564,"eighty":-9.421961,"marketCap":174325811},{"date":"2021-02-05","current":-31.400334,"twenty":-26.84195,"median":-12.529307,"eighty":-9.45474,"marketCap":277170746},{"date":"2021-02-12","current":-38.255446,"twenty":-28.281254,"median":-12.60197,"eighty":-9.456211,"marketCap":337680820},{"date":"2021-02-19","current":-37.135481,"twenty":-29.264756,"median":-12.640235,"eighty":-9.462094,"marketCap":327794891},{"date":"2021-02-26","current":-31.703043,"twenty":-30.554331,"median":-12.659911,"eighty":-9.472613,"marketCap":279842763},{"date":"2021-03-05","current":-26.934109,"twenty":-30.554331,"median":-12.982325,"eighty":-9.472613,"marketCap":237747383},{"date":"2021-03-12","current":-29.73593,"twenty":-30.417505,"median":-13.33841,"eighty":-9.474579,"marketCap":262479052},{"date":"2021-03-19","current":-27.939384,"twenty":-30.246813,"median":-13.55039,"eighty":-9.480014,"marketCap":246620943},{"date":"2021-03-26","current":-22.776896,"twenty":-30.090084,"median":-13.669721,"eighty":-9.490486,"marketCap":201051663},{"date":"2021-04-01","current":-23.313795,"twenty":-29.806761,"median":-13.754217,"eighty":-9.496445,"marketCap":205790868},{"date":"2021-04-09","current":-24.201743,"twenty":-29.62029,"median":-13.925431,"eighty":-9.506274,"marketCap":213628784},{"date":"2021-04-16","current":-22.652996,"twenty":-29.444186,"median":-14.142214,"eighty":-9.508359,"marketCap":199958000},{"date":"2021-04-23","current":-21.22815,"twenty":-29.293282,"median":-14.496146,"eighty":-9.514357,"marketCap":187380879},{"date":"2021-04-30","current":-17.711306,"twenty":-29.261736,"median":-15.17285,"eighty":-9.526996,"marketCap":209418477},{"date":"2021-05-07","current":-15.543838,"twenty":-28.831462,"median":-15.324978,"eighty":-9.541239,"marketCap":183790342},{"date":"2021-05-14","current":-14.537514,"twenty":-28.618492,"median":-15.17285,"eighty":-9.545905,"marketCap":171891565},{"date":"2021-05-21","current":-15.404501,"twenty":-28.589355,"median":-15.213615,"eighty":-9.550629,"marketCap":182142819},{"date":"2021-05-28","current":-12.053791,"twenty":-28.428574,"median":-15.07164,"eighty":-9.551697,"marketCap":171525449},{"date":"2021-06-04","current":-12.529768,"twenty":-28.19339,"median":-15.033591,"eighty":-9.558436,"marketCap":178298599},{"date":"2021-06-11","current":-12.285348,"twenty":-27.988944,"median":-14.630405,"eighty":-9.583805,"marketCap":174820495},{"date":"2021-06-18","current":-12.040927,"twenty":-27.886995,"median":-14.552996,"eighty":-9.608447,"marketCap":171342390},{"date":"2021-06-25","current":-11.938013,"twenty":-27.607099,"median":-14.369688,"eighty":-9.620266,"marketCap":169877926},{"date":"2021-07-02","current":-11.449172,"twenty":-27.273056,"median":-14.210669,"eighty":-9.642686,"marketCap":162921717},{"date":"2021-07-09","current":-10.522947,"twenty":-27.118197,"median":-14.096646,"eighty":-9.664912,"marketCap":149741533},{"date":"2021-07-16","current":-9.596722,"twenty":-27.015919,"median":-13.794982,"eighty":-9.664912,"marketCap":136561350},{"date":"2021-07-23","current":-9.570993,"twenty":-26.94655,"median":-13.721605,"eighty":-9.636251,"marketCap":136195233},{"date":"2021-07-30","current":-9.776821,"twenty":-26.925815,"median":-13.631921,"eighty":-9.628153,"marketCap":139124163},{"date":"2021-08-06","current":-10.589086,"twenty":-26.906399,"median":-13.428095,"eighty":-9.643412,"marketCap":151392158},{"date":"2021-08-13","current":-13.021886,"twenty":-26.825976,"median":-13.329925,"eighty":-9.664912,"marketCap":186173911},{"date":"2021-08-20","current":-13.226754,"twenty":-26.712777,"median":-13.317861,"eighty":-9.682201,"marketCap":189102901},{"date":"2021-08-27","current":-15.326645,"twenty":-26.670636,"median":-13.371023,"eighty":-9.692107,"marketCap":219125046},{"date":"2021-09-03","current":-15.00654,"twenty":-26.583373,"median":-13.517778,"eighty":-9.704975,"marketCap":214548499},{"date":"2021-09-10","current":-14.507175,"twenty":-26.507376,"median":-13.595792,"eighty":-9.714953,"marketCap":207409087},{"date":"2021-09-17","current":-14.91691,"twenty":-26.456266,"median":-13.697145,"eighty":-9.724684,"marketCap":213267066},{"date":"2021-09-24","current":-14.238287,"twenty":-26.422703,"median":-13.754217,"eighty":-9.741035,"marketCap":203564788},{"date":"2021-10-01","current":-12.154068,"twenty":-26.305176,"median":-13.713314,"eighty":-9.77839,"marketCap":173766711},{"date":"2021-10-08","current":-12.166875,"twenty":-26.15391,"median":-13.637109,"eighty":-9.784665,"marketCap":173949816},{"date":"2021-10-15","current":-11.885116,"twenty":-25.995727,"median":-13.55039,"eighty":-9.786233,"marketCap":169921504},{"date":"2021-10-22","current":-10.822115,"twenty":-25.825302,"median":-13.476436,"eighty":-9.79287,"marketCap":154723784},{"date":"2021-10-29","current":-10.553163,"twenty":-25.732176,"median":-13.329925,"eighty":-9.797932,"marketCap":150878577},{"date":"2021-11-05","current":-11.167911,"twenty":-25.699442,"median":-13.233156,"eighty":-9.814162,"marketCap":159667621},{"date":"2021-11-12","current":-10.578778,"twenty":-25.692352,"median":-13.021886,"eighty":-9.824129,"marketCap":151244787},{"date":"2021-11-19","current":-9.367411,"twenty":-25.673789,"median":-12.93377,"eighty":-9.824129,"marketCap":146094140},{"date":"2021-11-26","current":-8.897277,"twenty":-25.599535,"median":-12.742452,"eighty":-9.792506,"marketCap":138761937},{"date":"2021-12-03","current":-7.63967,"twenty":-25.590971,"median":-12.6477,"eighty":-9.732088,"marketCap":119148295},{"date":"2021-12-10","current":-7.81597,"twenty":-25.590971,"median":-12.629123,"eighty":-9.687087,"marketCap":121897871},{"date":"2021-12-17","current":-7.369343,"twenty":-25.558271,"median":-12.60197,"eighty":-9.623379,"marketCap":114932278},{"date":"2021-12-23","current":-7.28707,"twenty":-25.472761,"median":-12.542632,"eighty":-9.591576,"marketCap":113649143},{"date":"2021-12-31","current":-7.345837,"twenty":-25.399668,"median":-12.526145,"eighty":-9.556843,"marketCap":114565668},{"date":"2022-01-07","current":-7.099017,"twenty":-25.345397,"median":-12.520418,"eighty":-9.541239,"marketCap":110716262},{"date":"2022-01-14","current":-6.89921,"twenty":-25.261359,"median":-12.494045,"eighty":-9.506274,"marketCap":107600076},{"date":"2022-01-21","current":-6.464336,"twenty":-25.089038,"median":-12.473937,"eighty":-9.47784,"marketCap":100817788},{"date":"2022-01-28","current":-6.052969,"twenty":-24.79081,"median":-12.388261,"eighty":-9.459152,"marketCap":94402111},{"date":"2022-02-04","current":-5.817903,"twenty":-24.524483,"median":-12.339773,"eighty":-9.391964,"marketCap":90736009},{"date":"2022-02-11","current":-6.005956,"twenty":-24.41624,"median":-12.285348,"eighty":-9.347491,"marketCap":93668890},{"date":"2022-02-18","current":-6.147331,"twenty":-24.282838,"median":-12.223595,"eighty":-9.296205,"marketCap":95873781},{"date":"2022-02-25","current":-6.029792,"twenty":-24.185223,"median":-12.179682,"eighty":-9.24788,"marketCap":94040630},{"date":"2022-03-04","current":-5.81822,"twenty":-24.147801,"median":-12.154068,"eighty":-9.057963,"marketCap":90740959},{"date":"2022-03-11","current":-6.241363,"twenty":-23.991611,"median":-12.073087,"eighty":-8.920086,"marketCap":97340302},{"date":"2022-03-18","current":-6.300133,"twenty":-23.753921,"median":-12.040927,"eighty":-8.750736,"marketCap":98256877},{"date":"2022-03-25","current":-6.382411,"twenty":-23.656584,"median":-11.969729,"eighty":-8.684531,"marketCap":99540083},{"date":"2022-04-01","current":-6.717399,"twenty":-23.573984,"median":-11.938013,"eighty":-8.511768,"marketCap":104764562},{"date":"2022-04-08","current":-9.544232,"twenty":-23.553334,"median":-11.922729,"eighty":-8.511768,"marketCap":148851836},{"date":"2022-04-14","current":-8.686191,"twenty":-23.540944,"median":-11.894412,"eighty":-8.34487,"marketCap":135469836},{"date":"2022-04-22","current":-7.851659,"twenty":-23.495514,"median":-11.860828,"eighty":-8.255074,"marketCap":122454466},{"date":"2022-04-29","current":-7.225933,"twenty":-23.289015,"median":-11.77721,"eighty":-8.169363,"marketCap":104544799},{"date":"2022-05-06","current":-5.435324,"twenty":-23.166112,"median":-11.645343,"eighty":-8.041478,"marketCap":78638267},{"date":"2022-05-13","current":-5.435324,"twenty":-23.069985,"median":-11.624687,"eighty":-7.969071,"marketCap":78638267},{"date":"2022-05-20","current":-5.11784,"twenty":-23.032956,"median":-11.577814,"eighty":-7.881398,"marketCap":74044910},{"date":"2022-05-27","current":-4.448909,"twenty":-22.876016,"median":-11.551542,"eighty":-7.852492,"marketCap":86722575},{"date":"2022-06-03","current":-4.863637,"twenty":-22.776896,"median":-11.537249,"eighty":-7.827724,"marketCap":94806883},{"date":"2022-06-10","current":-4.010616,"twenty":-22.652996,"median":-11.500899,"eighty":-7.81597,"marketCap":78178931},{"date":"2022-06-17","current":-3.760836,"twenty":-22.529097,"median":-11.477248,"eighty":-7.72912,"marketCap":73309973},{"date":"2022-06-24","current":-4.373503,"twenty":-22.446497,"median":-11.464459,"eighty":-7.681738,"marketCap":85252701},{"date":"2022-07-01","current":-4.203842,"twenty":-22.376287,"median":-11.449172,"eighty":-7.640252,"marketCap":81945484},{"date":"2022-07-08","current":-5.278366,"twenty":-22.305556,"median":-11.438627,"eighty":-7.613627,"marketCap":102891191},{"date":"2022-07-15","current":-4.627996,"twenty":-22.101984,"median":-11.428444,"eighty":-7.55138,"marketCap":90213526},{"date":"2022-07-22","current":-3.987052,"twenty":-21.967418,"median":-11.387691,"eighty":-7.503446,"marketCap":77719596},{"date":"2022-07-29","current":-4.005903,"twenty":-21.913728,"median":-11.301792,"eighty":-7.431035,"marketCap":78087064},{"date":"2022-08-05","current":-4.863637,"twenty":-21.888948,"median":-11.237452,"eighty":-7.399356,"marketCap":94806883},{"date":"2022-08-12","current":-4.797658,"twenty":-21.862089,"median":-11.216095,"eighty":-7.353705,"marketCap":93520743},{"date":"2022-08-19","current":-4.825935,"twenty":-21.677916,"median":-11.173407,"eighty":-7.324758,"marketCap":94071946},{"date":"2022-08-26","current":-4.004998,"twenty":-21.508695,"median":-11.14152,"eighty":-7.292354,"marketCap":105323427},{"date":"2022-09-02","current":-3.606595,"twenty":-21.463334,"median":-11.116916,"eighty":-7.270111,"marketCap":94846228},{"date":"2022-09-09","current":-3.424867,"twenty":-21.405349,"median":-11.08117,"eighty":-7.237681,"marketCap":90067154},{"date":"2022-09-16","current":-3.368951,"twenty":-21.286149,"median":-11.075135,"eighty":-7.177095,"marketCap":88596670},{"date":"2022-09-23","current":-2.872695,"twenty":-21.208634,"median":-11.058612,"eighty":-7.086181,"marketCap":75546123},{"date":"2022-09-30","current":-2.970548,"twenty":-21.177073,"median":-11.028796,"eighty":-7.033351,"marketCap":78119471},{"date":"2022-10-07","current":-2.98112,"twenty":-21.121105,"median":-11.001417,"eighty":-6.964376,"marketCap":78397482},{"date":"2022-10-14","current":-2.918138,"twenty":-21.020838,"median":-10.97259,"eighty":-6.897942,"marketCap":76741198},{"date":"2022-10-21","current":-3.042212,"twenty":-20.985326,"median":-10.924573,"eighty":-6.845568,"marketCap":80004079},{"date":"2022-10-28","current":-3.019608,"twenty":-20.977642,"median":-10.867286,"eighty":-6.810107,"marketCap":79409656},{"date":"2022-11-04","current":-3.009111,"twenty":-20.903933,"median":-10.84773,"eighty":-6.664507,"marketCap":79133609},{"date":"2022-11-11","current":-3.219049,"twenty":-20.756177,"median":-10.82938,"eighty":-6.546173,"marketCap":84654559},{"date":"2022-11-18","current":-3.358938,"twenty":-20.668581,"median":-10.726981,"eighty":-6.478794,"marketCap":88333351},{"date":"2022-11-25","current":-3.261037,"twenty":-20.630862,"median":-10.714226,"eighty":-6.373008,"marketCap":85758748},{"date":"2022-12-02","current":-2.870497,"twenty":-20.600195,"median":-10.688457,"eighty":-6.299858,"marketCap":82116306},{"date":"2022-12-09","current":-2.773956,"twenty":-20.530642,"median":-10.652221,"eighty":-6.276625,"marketCap":79354547},{"date":"2022-12-16","current":-2.568001,"twenty":-20.466533,"median":-10.603143,"eighty":-6.251552,"marketCap":73462794},{"date":"2022-12-23","current":-2.50364,"twenty":-20.27992,"median":-10.586676,"eighty":-6.168488,"marketCap":71621621},{"date":"2022-12-30","current":-2.534211,"twenty":-20.15537,"median":-10.584284,"eighty":-6.147331,"marketCap":72496179},{"date":"2023-01-06","current":-2.735339,"twenty":-20.094824,"median":-10.578778,"eighty":-6.048334,"marketCap":78249844},{"date":"2023-01-13","current":-2.812057,"twenty":-20.035005,"median":-10.550787,"eighty":-6.001255,"marketCap":80444521},{"date":"2023-01-20","current":-2.670978,"twenty":-19.978946,"median":-10.539281,"eighty":-5.966125,"marketCap":76408671},{"date":"2023-01-27","current":-2.844753,"twenty":-19.92865,"median":-10.527112,"eighty":-5.924006,"marketCap":81379837},{"date":"2023-02-03","current":-2.83188,"twenty":-19.914681,"median":-10.518845,"eighty":-5.829586,"marketCap":81011603},{"date":"2023-02-10","current":-2.7997,"twenty":-19.912392,"median":-10.5062,"eighty":-5.803799,"marketCap":80091016},{"date":"2023-02-17","current":-2.638798,"twenty":-19.895957,"median":-10.459125,"eighty":-5.435324,"marketCap":75488084},{"date":"2023-02-24","current":-2.471459,"twenty":-19.873903,"median":-10.442134,"eighty":-5.343888,"marketCap":70701035},{"date":"2023-03-03","current":-2.53582,"twenty":-19.846258,"median":-10.408105,"eighty":-5.257533,"marketCap":72542208},{"date":"2023-03-10","current":-2.336301,"twenty":-19.83179,"median":-10.356918,"eighty":-5.11784,"marketCap":66834572},{"date":"2023-03-17","current":-2.291249,"twenty":-19.827342,"median":-10.280555,"eighty":-4.987615,"marketCap":65545751},{"date":"2023-03-24","current":-2.297685,"twenty":-19.792064,"median":-10.24585,"eighty":-4.882489,"marketCap":65729868},{"date":"2023-03-31","current":-2.342737,"twenty":-19.702524,"median":-10.187527,"eighty":-4.844757,"marketCap":67018689},{"date":"2023-04-06","current":-1.686256,"twenty":-19.632558,"median":-10.178515,"eighty":-4.82782,"marketCap":48238727},{"date":"2023-04-14","current":-1.761523,"twenty":-19.623856,"median":-10.152662,"eighty":-4.778806,"marketCap":54712900},{"date":"2023-04-21","current":-1.74373,"twenty":-19.588234,"median":-10.098427,"eighty":-4.644962,"marketCap":54160244},{"date":"2023-04-28","current":-1.714074,"twenty":-19.576906,"median":-10.035554,"eighty":-4.518659,"marketCap":53239152},{"date":"2023-05-05","current":-1.654764,"twenty":-19.545187,"median":-10.025454,"eighty":-4.450794,"marketCap":51396967},{"date":"2023-05-12","current":-1.672557,"twenty":-19.516872,"median":-10.012699,"eighty":-4.39047,"marketCap":51949622},{"date":"2023-05-19","current":-1.589522,"twenty":-19.460547,"median":-9.999892,"eighty":-4.266051,"marketCap":49370563},{"date":"2023-05-26","current":-1.57766,"twenty":-19.427915,"median":-9.975789,"eighty":-4.215152,"marketCap":49002126},{"date":"2023-06-02","current":-1.506488,"twenty":-19.352412,"median":-9.936043,"eighty":-4.127494,"marketCap":46791504},{"date":"2023-06-09","current":-1.601384,"twenty":-19.277733,"median":-9.905463,"eighty":-4.005903,"marketCap":49739000},{"date":"2023-06-16","current":-1.666626,"twenty":-19.224922,"median":-9.888874,"eighty":-3.984029,"marketCap":51765404},{"date":"2023-06-22","current":-1.685692,"twenty":-19.216442,"median":-9.879735,"eighty":-3.907876,"marketCap":50660093},{"date":"2023-06-30","current":-1.590794,"twenty":-19.208775,"median":-9.865308,"eighty":-3.854893,"marketCap":47808124},{"date":"2023-07-07","current":-1.507393,"twenty":-19.20072,"median":-9.828261,"eighty":-3.760836,"marketCap":45301679},{"date":"2023-07-14","current":-1.427081,"twenty":-19.193508,"median":-9.794325,"eighty":-3.690469,"marketCap":42888065},{"date":"2023-07-21","current":-1.507393,"twenty":-19.088098,"median":-9.784665,"eighty":-3.638302,"marketCap":45301679},{"date":"2023-07-28","current":-1.47082,"twenty":-18.913767,"median":-9.732088,"eighty":-3.592616,"marketCap":44202556},{"date":"2023-08-04","current":-1.834818,"twenty":-18.866187,"median":-9.706309,"eighty":-3.410888,"marketCap":55141798},{"date":"2023-08-11","current":-1.587705,"twenty":-18.752044,"median":-9.678943,"eighty":-3.358938,"marketCap":47715293},{"date":"2023-08-18","current":-1.54446,"twenty":-18.637901,"median":-9.629347,"eighty":-3.268035,"marketCap":46415655},{"date":"2023-08-25","current":-1.482682,"twenty":-18.599214,"median":-9.603002,"eighty":-3.22916,"marketCap":44559028},{"date":"2023-09-01","current":-1.476504,"twenty":-18.588983,"median":-9.583858,"eighty":-3.170064,"marketCap":44373366},{"date":"2023-09-08","current":-1.599351,"twenty":-18.484624,"median":-9.566961,"eighty":-3.120328,"marketCap":43073727},{"date":"2023-09-15","current":-1.305186,"twenty":-18.093277,"median":-9.551697,"eighty":-3.053757,"marketCap":35151268},{"date":"2023-09-22","current":-1.084202,"twenty":-17.998272,"median":-9.545293,"eighty":-3.017509,"marketCap":29199731},{"date":"2023-09-29","current":-1.035862,"twenty":-17.946983,"median":-9.529781,"eighty":-3.000867,"marketCap":27897832},{"date":"2023-10-06","current":-1.069424,"twenty":-17.910179,"median":-9.508359,"eighty":-2.980403,"marketCap":28801722},{"date":"2023-10-13","current":-0.92537,"twenty":-17.786722,"median":-9.490486,"eighty":-2.958726,"marketCap":24922063},{"date":"2023-10-20","current":-0.994427,"twenty":-17.748788,"median":-9.473596,"eighty":-2.934164,"marketCap":26781919},{"date":"2023-10-27","current":-0.904653,"twenty":-17.745767,"median":-9.472613,"eighty":-2.925793,"marketCap":24364107},{"date":"2023-11-03","current":-0.97371,"twenty":-17.742028,"median":-9.45474,"eighty":-2.910919,"marketCap":26223962},{"date":"2023-11-10","current":-1.208506,"twenty":-17.735112,"median":-9.411049,"eighty":-2.890849,"marketCap":32547471},{"date":"2023-11-17","current":-1.191425,"twenty":-17.657513,"median":-9.365376,"eighty":-2.873386,"marketCap":32361485},{"date":"2023-11-24","current":-1.321523,"twenty":-17.442343,"median":-9.347503,"eighty":-2.851189,"marketCap":35895211},{"date":"2023-12-01","current":-1.259898,"twenty":-17.38233,"median":-9.315219,"eighty":-2.83188,"marketCap":34221341},{"date":"2023-12-08","current":-1.170883,"twenty":-17.336289,"median":-9.293885,"eighty":-2.806136,"marketCap":31803529},{"date":"2023-12-15","current":-0.986007,"twenty":-17.300799,"median":-9.252569,"eighty":-2.773956,"marketCap":26781919},{"date":"2023-12-22","current":-1.561178,"twenty":-17.246848,"median":-9.139522,"eighty":-2.767519,"marketCap":42404705},{"date":"2023-12-29","current":-1.766596,"twenty":-17.221185,"median":-9.061538,"eighty":-2.760774,"marketCap":47984271},{"date":"2024-01-05","current":-2.506101,"twenty":-17.167981,"median":-8.982854,"eighty":-2.752073,"marketCap":68070711},{"date":"2024-01-12","current":-2.067876,"twenty":-17.020028,"median":-8.925788,"eighty":-2.723754,"marketCap":56167636},{"date":"2024-01-19","current":-1.828221,"twenty":-17.00576,"median":-8.789589,"eighty":-2.677414,"marketCap":49658141},{"date":"2024-01-26","current":-1.985708,"twenty":-16.968174,"median":-8.734252,"eighty":-2.645234,"marketCap":53935809},{"date":"2024-02-02","current":-1.882999,"twenty":-16.939654,"median":-8.685954,"eighty":-2.625925,"marketCap":51146026},{"date":"2024-02-09","current":-1.807679,"twenty":-16.938913,"median":-8.684531,"eighty":-2.593745,"marketCap":49100185},{"date":"2024-02-16","current":-2.197974,"twenty":-16.925758,"median":-8.618237,"eighty":-2.567726,"marketCap":59701361},{"date":"2024-02-23","current":-2.115806,"twenty":-16.770447,"median":-8.515294,"eighty":-2.531958,"marketCap":57469534},{"date":"2024-03-01","current":-2.126077,"twenty":-16.704302,"median":-8.333117,"eighty":-2.50364,"marketCap":57748513},{"date":"2024-03-08","current":-2.314377,"twenty":-16.616611,"median":-8.290129,"eighty":-2.482023,"marketCap":62863115},{"date":"2024-03-15","current":-2.821075,"twenty":-16.559853,"median":-8.227337,"eighty":-2.484293,"marketCap":76626046},{"date":"2024-03-22","current":-2.45817,"twenty":-16.504894,"median":-8.169883,"eighty":-2.484293,"marketCap":66768812},{"date":"2024-03-28","current":-2.643046,"twenty":-16.389693,"median":-8.076394,"eighty":-2.485232,"marketCap":71790422},{"date":"2024-04-05","current":-2.405758,"twenty":-15.948064,"median":-7.968764,"eighty":-2.478712,"marketCap":69930566},{"date":"2024-04-12","current":-1.170887,"twenty":-15.749184,"median":-7.872428,"eighty":-2.477895,"marketCap":34035355},{"date":"2024-04-19","current":-0.895761,"twenty":-15.429079,"median":-7.832767,"eighty":-2.455369,"marketCap":26037977},{"date":"2024-04-26","current":-0.938389,"twenty":-15.339387,"median":-7.81597,"eighty":-2.391538,"marketCap":27277081},{"date":"2024-05-03","current":-1.048407,"twenty":-15.197309,"median":-7.721716,"eighty":-2.342737,"marketCap":30475083},{"date":"2024-05-10","current":-0.98369,"twenty":-15.027656,"median":-7.656232,"eighty":-2.318762,"marketCap":28593905},{"date":"2024-05-17","current":-0.90603,"twenty":-14.795359,"median":-7.610665,"eighty":-2.292536,"marketCap":26336492},{"date":"2024-05-24","current":-0.886421,"twenty":-14.604487,"median":-7.535422,"eighty":-2.26208,"marketCap":25766495},{"date":"2024-05-31","current":-0.948916,"twenty":-14.531446,"median":-7.494663,"eighty":-2.239057,"marketCap":27583083},{"date":"2024-06-07","current":-0.970075,"twenty":-14.326486,"median":-7.40862,"eighty":-2.197974,"marketCap":28198129},{"date":"2024-06-14","current":-1.039667,"twenty":-14.137411,"median":-7.369343,"eighty":-2.115806,"marketCap":30221038},{"date":"2024-06-21","current":-1.062541,"twenty":-14.007811,"median":-7.327858,"eighty":-2.065137,"marketCap":27615452},{"date":"2024-06-28","current":-1.204604,"twenty":-13.78846,"median":-7.297759,"eighty":-2.010359,"marketCap":31307670},{"date":"2024-07-05","current":-1.068083,"twenty":-13.686175,"median":-7.275317,"eighty":-1.965166,"marketCap":27759467},{"date":"2024-07-12","current":-1.140359,"twenty":-13.4847,"median":-7.225933,"eighty":-1.911758,"marketCap":29637927},{"date":"2024-07-15","current":-1.188543,"twenty":-13.480277,"median":-7.22569,"eighty":-1.899433,"marketCap":30890234},{"date":"2024-08-02","current":-1.068083,"twenty":-12.841755,"median":-7.076567,"eighty":-1.873413,"marketCap":27759467},{"date":"2024-08-09","current":-1.01323,"twenty":-12.643221,"median":-7.016084,"eighty":-1.812305,"marketCap":26333856},{"date":"2024-08-16","current":-0.994348,"twenty":-12.560908,"median":-6.91684,"eighty":-1.766596,"marketCap":25843098},{"date":"2024-08-23","current":-1.036532,"twenty":-12.52126,"median":-6.849695,"eighty":-1.758351,"marketCap":26939472},{"date":"2024-08-30","current":-1.000374,"twenty":-12.473063,"median":-6.799492,"eighty":-1.736271,"marketCap":25999723},{"date":"2024-09-06","current":-1.15217,"twenty":-12.364107,"median":-6.617311,"eighty":-1.714074,"marketCap":25686473},{"date":"2024-09-13","current":-1.48939,"twenty":-12.253473,"median":-6.523281,"eighty":-1.688712,"marketCap":33204466},{"date":"2024-09-20","current":-1.405085,"twenty":-12.158042,"median":-6.376534,"eighty":-1.682047,"marketCap":31324968},{"date":"2024-09-27","current":-1.480023,"twenty":-12.045958,"median":-6.294084,"eighty":-1.667461,"marketCap":32995632},{"date":"2024-10-04","current":-1.480023,"twenty":-11.943159,"median":-6.276454,"eighty":-1.655339,"marketCap":32995632},{"date":"2024-10-11","current":-1.430653,"twenty":-11.893709,"median":-6.211978,"eighty":-1.650019,"marketCap":31894986},{"date":"2024-10-18","current":-1.565077,"twenty":-11.8243,"median":-6.129701,"eighty":-1.628561,"marketCap":34891830},{"date":"2024-10-25","current":-1.459458,"twenty":-11.642894,"median":-6.018038,"eighty":-1.618203,"marketCap":32537167},{"date":"2024-10-31","current":-1.325035,"twenty":-11.642894,"median":-5.976572,"eighty":-1.608313,"marketCap":29540322},{"date":"2024-11-08","current":-1.219416,"twenty":-11.643711,"median":-5.888744,"eighty":-1.60059,"marketCap":27185659},{"date":"2024-11-15","current":-1.036984,"twenty":-11.643711,"median":-5.81822,"eighty":-1.590031,"marketCap":23118513},{"date":"2024-11-22","current":-0.807503,"twenty":-11.643711,"median":-5.486121,"eighty":-1.582353,"marketCap":18002472},{"date":"2024-11-29","current":-1.094594,"twenty":-11.643711,"median":-5.397226,"eighty":-1.572515,"marketCap":24402875},{"date":"2024-12-06","current":-1.416956,"twenty":-11.643711,"median":-5.257533,"eighty":-1.561904,"marketCap":26827233},{"date":"2024-12-13","current":-1.405342,"twenty":-11.643711,"median":-5.054343,"eighty":-1.546931,"marketCap":26607338},{"date":"2024-12-20","current":-1.370499,"twenty":-11.607051,"median":-4.90134,"eighty":-1.532584,"marketCap":25947652},{"date":"2024-12-27","current":-1.4518,"twenty":-11.552128,"median":-4.863637,"eighty":-1.513321,"marketCap":27486920},{"date":"2025-01-03","current":-1.440185,"twenty":-11.551659,"median":-4.83536,"eighty":-1.507393,"marketCap":27267024},{"date":"2025-01-10","current":-1.370499,"twenty":-11.551894,"median":-4.778806,"eighty":-1.501215,"marketCap":25947652},{"date":"2025-01-17","current":-1.335656,"twenty":-11.533445,"median":-4.609145,"eighty":-1.488965,"marketCap":25287966},{"date":"2025-01-24","current":-1.382113,"twenty":-11.478602,"median":-4.496037,"eighty":-1.480555,"marketCap":26167547},{"date":"2025-01-31","current":-1.289198,"twenty":-11.469754,"median":-4.439483,"eighty":-1.471957,"marketCap":24408384},{"date":"2025-02-07","current":-1.196283,"twenty":-11.469754,"median":-4.293385,"eighty":-1.469209,"marketCap":22649222},{"date":"2025-02-14","current":-1.207897,"twenty":-11.469754,"median":-4.21798,"eighty":-1.451921,"marketCap":22869117},{"date":"2025-02-21","current":-1.18281,"twenty":-11.449172,"median":-4.115172,"eighty":-1.4518,"marketCap":22394143},{"date":"2025-02-28","current":-1.196283,"twenty":-11.43059,"median":-4.000737,"eighty":-1.440659,"marketCap":22649222},{"date":"2025-03-07","current":-1.335656,"twenty":-11.33139,"median":-3.902221,"eighty":-1.428571,"marketCap":25287966},{"date":"2025-03-14","current":-1.265969,"twenty":-11.33139,"median":-3.760836,"eighty":-1.425853,"marketCap":23968594},{"date":"2025-03-21","current":-1.265969,"twenty":-11.33139,"median":-3.68348,"eighty":-1.414452,"marketCap":23968594},{"date":"2025-03-28","current":-1.173054,"twenty":-11.33139,"median":-3.613584,"eighty":-1.405085,"marketCap":22209431},{"date":"2025-04-04","current":-1.386099,"twenty":-11.33139,"median":-3.424867,"eighty":-1.393728,"marketCap":20810896},{"date":"2025-04-11","current":-1.449241,"twenty":-11.329432,"median":-3.358973,"eighty":-1.393728,"marketCap":21758909},{"date":"2025-04-17","current":-1.354726,"twenty":-11.329432,"median":-3.271534,"eighty":-1.393728,"marketCap":20339850},{"date":"2025-04-25","current":-1.512252,"twenty":-11.33139,"median":-3.219049,"eighty":-1.391372,"marketCap":22704949},{"date":"2025-05-02","current":-1.654025,"twenty":-11.33139,"median":-3.14907,"eighty":-1.391372,"marketCap":24833538},{"date":"2025-05-09","current":-1.638273,"twenty":-11.33139,"median":-3.054422,"eighty":-1.391372,"marketCap":24597028},{"date":"2025-05-16","current":-1.636168,"twenty":-11.33139,"median":-3.009111,"eighty":-1.391372,"marketCap":24565433},{"date":"2025-05-23","current":-1.528308,"twenty":-11.33139,"median":-2.995115,"eighty":-1.391372,"marketCap":22946022},{"date":"2025-05-30","current":-1.489391,"twenty":-11.33139,"median":-2.970548,"eighty":-1.391372,"marketCap":22361722},{"date":"2025-06-06","current":-1.521043,"twenty":-11.33139,"median":-2.94613,"eighty":-1.391372,"marketCap":21790456},{"date":"2025-06-13","current":-1.554109,"twenty":-11.33139,"median":-2.925136,"eighty":-1.391372,"marketCap":22264162}],"updateTime":1749985856559}}}